Antony A. Riley, Chief Financial Officer at Krystal Biotech, Inc. (KRYS), bought 2,800 shares at $10.75 ($30K) on 2018-05-22, disclosed to the SEC on 2018-05-24.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| FBRX | SELL | 2021-09-07 | $197K | — | Filing → |
| FBRX | BUY | 2020-06-30 | $96K | — | Filing → |